In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the unaudited standalone and consolidated financial results along with the limited review report, is attached for the second quarter ended 30 September 2026 for the financial year 2026-27.

SAMPRE NUTRITIONS LIMITED CIN: L15499TG1991PLC013515 Date: 06 November 2026 BSE Limited 2nd Floor, New Trading Wing, Rotunda Building, P.J. Towers, Dalal Street, Fort, Mumbai - 400001, MH Subject: Outcome of the Board Meeting of the Company Reference: BSE Symbol: SAMPRE; BSE Scrip Code: 530617 Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and in reference to our letters dated 02 November 2026, we wish to inform you that the Board of Directors of Sampre Nutritions Limited (“the Company”) at their meeting held today i.e., 06 November 2026, have, inter-alia approved the standalone and consolidated unaudited financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27. Under Regulation 33 of the Listing Regulations, we enclose herewith a copy of the standalone and consolidated unaudited financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27, accompanied by the limited review report(s) issued by the statutory auditors of the Company. The Board Meeting commenced at 03:00 P.M. (IST) and concluded on 05:00 P.M. (IST). The aforesaid information is also being hosted on the Company’s website at www.gurbanigroup.in. Kindly take the above information on record and acknowledge the receipt of the same. Thanking you. Sincerely, For Sampre Nutritions Limited Vishal Ratan Gurbani Whole-Time Director (DIN: 07738685) Enclosed: As above Regd. Off & Works: Unit-1: Plot No. 133, I.E, Medchal - 501401, Telangana, India. Ph: +91-8418-222428 Unit-2: Plot No. 127, 128, Royes Building, I.E. Medchal, Malkajgiri - 501401.Telangana. e-mail: gurbani@gurbanigroup.in, bkgurbani@gurbanigroup.in, www.gurbanigroup.in SAMPRE NUTRITIONS LIMITED SAMPRE NUTRITIONS LIMITED CIN: L15499TG1991PLCO13515 Registered Office: Plot No.133, Industrial Estate, Medchal - 501 401 Website: www.sampreltd.com;Email: gurbani@gurbanigroup.in Statement of Standalone Un-Audited Financial Results for the 2nd Quarter& Half year ended 30th September 2026 (In Lakhs) Quarter ended Half year ended Financial Year § ended Particulars 30.09.2026 | 30.06.2026 | 30.09.2025 | 30.09.2026 | 30.09.2025 31.03.2026 Un-Audited | Un-Audited | Un-Audited | Un-Audited | Un-Audited Audited 1__[Revenue from operations 1.328.94] 148480 999.74] 281374 | 2,08639 4334.73 Il_|Other income 0.49) 673 0.54] 7.22 304 71.09) I} Total Revenue (I+11) 1,329.43 149153 1000.28 2620.96] 2089.43 4405.76} IV_|Expenses: Cost of materials consumed 588,69 635.95] 325.73) 1,224 5| 72027 1,491.00) Purchases of Stock-in-Trade - | . (Changes in inventories of finished goods work-in- progress and Stock-in-Trade | ) | | i Employee benefits expense 368632 509.93) 269.47] 896.25 586,34 1.337.03] Finance costs 45 83| 2569 28.34] 71.52 59.15 136.78 Depreciation and amorlization expense 51.15] 51.15] 60.97] 102.30) 100.23] 204.59) Other expenses 193.69] 188.92] 211.62| 382.60 445.35 7.8 Total expenses 1,265.61] 141165 894.13 2677.26] 1912.34] 4149.23] v |Profit before exceptional and extraordinary items 382 7088 P P— . e and tax (il - IV) VI_|Exceptional items & extraordinary tems - B - = = - VII_|Profit before tax (V - Vi) 63.82 79.88 106.15] 143.70) 177.09 256.53 Tax expense: Vil [(7) Current tax 11.12] 9.67] 16.68 2079 16.68 - (2) Deferred tax ] - | - - (130.02) Profit (Loss) for the period from continuing X |o perations (VILVIl 52.70) 70.21 89.47] 12291 160.41 386.55 X__|Profit/(loss) from discontinuing operations E - | ] ] n XI_|Tax expense of discontinuing operations - B ] ] ] g xi_|Profitl(loss) from Discontinuing operations (after i i i ] i ] tax) (X-XI) XIll_|Profit (Loss) for the period (IX + X} 5270 7021 89.47) 122,91 160.41 386.55 XIV_|Other Comphrensive Income - - | | | - - ltems that will not be reclassified to profit or loss E - | ] ] ~Income tax relaling to items thal will not be reclassified to profit or loss. ] | l l | ) - Items that will be reclassified to profit or loss E - | - - - ~Income tax relating 1o items that will be reclassified to profit or loss 1 i | ] i ] XV Total comprehensive income for the period 52.70 70.21 89.47 12291 160.41 386.55 (XIIHXIV) Earnings per equity share: (For continuing operation) xvi [() Basic 0.24] 0.33] 0.41 056 0.73) 1.84 (2) Diluted 0.24] 0.50] 0.41 0.56 0.74] 2.73 Earnings per equity share: (For discontinued operation) (2) Diluted 1 g ] ] ] g Eamnings per equity share: (For discontinued & continuing operation) xvill- [(1) Basic 0.24] 0.33] 0.41 0.59) 0.73) 1.84 (2) Diluted 0.24] 0.50) 0.41 056 0.74] 2.73) INOTES: 1. The results have been prepared in accordance with the India Accounting Standards ("Ind AS) as prescribed under Section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended. 2. The above results have been reviewed by the Audit Committes and thereafter approved by the Board of Directors in their respective meetings held on 06 t November, 2026 These results have been subject to limited review by the Statutory Auditors. = 3. Figures of previous period have been re-grouped wherever necessary to make them comparable. For SAMPRE NUTRI Date: 06.11.2026 Place : Medchal (CIN: L15499TG1991PLC013515) Regd. Off& Work: Unit-1: Plot No. 133, L.E, Medchal-501401. Telangana, India. Ph: +91-8418-222428 Unit-2: Plot No. 127,128, Royes Building, I.E.Medchal, Malkajgiri-501401.Telangana. E-mail:gurbani@gurbanigroup.in, www.gurbanigroup.in. (SAMPRE) SAMPRE NUTRITIONS LIMITED SAMPRE NUTRITIONS LIMITED STATEMENT OF STANDALONE ASSETS AND LIABILITIES AS AT 30TH SEPTEMBER, 2026 (In Lakhs) As at As at PARTICULARS 30.09.2026 31.03.2026 Unaudited Audited ASSETS 1 |Non -current assets a. Property,plantand equipment 1,962.39 2009.84| b. Capital work-in-progress 500.53| 500.53| c. Investment properties - - d. Good will - - e. Other Intangible assets - - f. Intangible assets under development = - g.Biological assets other than bearer plants - - h. Financial assets = - - Investments 7,149.38 7,149.38 -Trade Receivable - - -Long -term loans and advances - - -Others 620.55 705.16 i. Deferred tax assets (net) 54.33 54.33 j. Other non - current assets - - 2 [Current assets a.Inventories 79215 759.60] b. Financial assets - Current Investments - Trade and other receivables 1.253.25 1328.02 - Cash and cash equivalents 520 6.25 - Bank balance other than(iii) above - Short term loans and advances 166.46 184.76 c. Assets for current tax (net) - - d.Other current assets - - Total Assets 12504.24| 12697.87, EQUITY AND LIABILITIES 1 |Equity Equity share capital 4,838.98 4750.45 Other equity 6,051.38 5273.31 2 |Non -current liabilities a. Financial liabilities - Long term borrowings 513.12 1275.28 - Other financial liabilities b.Long term provisions c.Deferred tax liabilities (Net) - - d.Other non-current liabilities - - 3 |Current liabilities a.Financial liabilities -Short term borrowings 384.31 515.73 -Trade and other payables 541.08 550.46| - Other financial liabilities - - b.Other Current liabilities 154.58 332,64 c.Short- term Provisions 20.79 - d.Liabilities for current tax (net) Total Equity & liabilities 12504.24) ,\“‘R‘ “ON?\?§?@97.87 (Y No 185\ %! 3 il (CIN: L15499TG1991PLC013515) S '4("‘»,, ‘.wfy Regd. Off & Work: Unit-1: Plot No. 133, L.E, Medchal-501401. Telangana, India. Ph: 418-222428 Unit-2; Plot No. 127,128, Royes Building, |.E.Medchal, Malkajgiri-501401.Telangana. E-mail:gurbani@gurbanigroup.in, www.gurbanigroup.in. SAMPRE NUTRITIONS LIMITED SAMPRE NUTRITIONS LIMITED Standalone Cash flow statement for the Half- year ended 30th September, 2026 (All amounts are in Indian rupees except as otherwise stated) (In Lakhs) PARTICULARS 30-Sep-26 31-Mar-26 A. Cash flow from operating activities Profit/ (loss) before tax 143.70 256.53 Non-cash adjustment to reconcile profit before tax to net cash flows Depreciation expense 102.30 204.60 Profit / (L [Showing first 8,000 characters — download PDF for full document]